Retinal diseases are at the forefront of a quiet revolution in the realm of ophthalmology. Gene therapy, once a distant dream, is now emerging as a beacon of hope for millions affected by these ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

The retina is a thin layer of neural tissue at the back of the eye that detects light and converts it into signals, sent to ...

OCGN's gene-agnostic eye therapy aims to treat multiple retinal mutations, with key filings and pivotal data in 2026???2027 set to test its broad platform.

Please provide your email address to receive an email when new articles are posted on . Errors of refraction and strabismic amblyopia were the most common causes of low vision. Retinal diseases most ...

Walter and Eliza Hall Institute of Medical Research in Victoria, Australia led one of the largest eye studies in the world that used AI to analyse eye images of over 50,000 people to better understand ...

The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully replicates the structural layers and microvascular network of the human ...

We present one of the first comprehensive evaluations of predictive information derived from retinal fundus photographs, ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Back ...

This activity is supported by independent educational grants from Apellis Pharmaceuticals, Inc.; Astellas; Eyepoint Pharmaceuticals, Inc.; Genentech, a member of the ...

The retina, as an accessible extension of the central nervous system, offers a unique window into the microvascular changes associated with Alzheimer’s disease. Recent studies have demonstrated that ...